Literature DB >> 8582995

Epidermal growth factor receptors in placentae and fetal membranes from hypertension-complicated pregnancies.

G Ferrandina1, A Lanzone, G Scambia, A Caruso, P B Panici, S Mancuso.   

Abstract

Epidermal growth factor receptor concentrations (EGFR) in placentae and fetal membranes from 25 normal and 25 hypertension-complicated pregnancies were analysed by a radioreceptor technique. Higher EGFR concentrations were found in placentae from hypertension-complicated pregnancies than in those from normal pregnancies (median 125.0 fmol/mg protein, range: 33.4-190.7 versus median 50.3 fmol/mg protein, range 21.4-184.0) (P = 0.0002). EGFR concentrations were significantly lower in fetal membranes than in placental tissue, both in normal membranes (median 31.7, range 4.8-92.0 versus median 50.3, range 21.4-184.0) (P = 0.0004) and in hypertension-complicated pregnancies (median 65.0, range 16.8-125.0 versus median 125.0, range 33.4-190.7) (P = 0.0001). A statistically significant inverse correlation between EGFR concentrations and gestational age was found in placentae (r = 0.53, P = 0.0061) and fetal membranes (r = 0.56, P = 0.0032) from hypertension-complicated pregnancies. Multiple regression analyses demonstrated that hypertensive disease is more closely associated with EGFR concentrations than gestational age and fetal weight in placental tissue and fetal membranes. Our findings suggest that hypertensive disorders in pregnancy are associated with elevated EGFR concentrations in both the placenta and fetal membranes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8582995     DOI: 10.1093/oxfordjournals.humrep.a136189

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  2 in total

1.  Altered trophoblast proliferation is insufficient to account for placental dysfunction in Egfr null embryos.

Authors:  J Dackor; K E Strunk; M M Wehmeyer; D W Threadgill
Journal:  Placenta       Date:  2007-09-05       Impact factor: 3.481

2.  Epidermal growth factor abrogates hypoxia-induced apoptosis in cultured human trophoblasts through phosphorylation of BAD Serine 112.

Authors:  Rachel G Humphrey; Christina Sonnenberg-Hirche; Steven D Smith; Chaobin Hu; Aaron Barton; Yoel Sadovsky; D Michael Nelson
Journal:  Endocrinology       Date:  2008-02-14       Impact factor: 4.736

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.